CL2004002016A1 - THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST - Google Patents

THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST

Info

Publication number
CL2004002016A1
CL2004002016A1 CL2004002016A CL2004002016A CL2004002016A1 CL 2004002016 A1 CL2004002016 A1 CL 2004002016A1 CL 2004002016 A CL2004002016 A CL 2004002016A CL 2004002016 A CL2004002016 A CL 2004002016A CL 2004002016 A1 CL2004002016 A1 CL 2004002016A1
Authority
CL
Chile
Prior art keywords
abuse
optionally
proof
dosage form
auxiliary substances
Prior art date
Application number
CL2004002016A
Other languages
Spanish (es)
Inventor
Johannes Kugelman Bartholomaus
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40261417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004002016(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10336400A external-priority patent/DE10336400A1/en
Priority claimed from DE10361596A external-priority patent/DE10361596A1/en
Priority claimed from DE102004020220A external-priority patent/DE102004020220A1/en
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of CL2004002016A1 publication Critical patent/CL2004002016A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA FORMA DE DOSIFICACION TERMOFORMADA MEDIANTE EXTRUSION SIN DECOLORACION A PRUEBA DE ABUSO QUE CONTIENE ADEMAS, DE UNOS O MAS PRINCIPIOS ACTIVOS SUSCEPTIBLES DE ABUSO Y OPCIONALMENTE SUSTANCIAS AUXILIARES FISIOLOGICAMENTE ACEPTABLES, AL MENOS UN POLIMERO SINTETICO O NATURAL CON UNA DUREZA DE AL MENOS 500 N Y UN PROCESO DE PREPARACION DE LA MISMA.THE PRESENT INVENTION REFERS TO A THERMOFORMED DOSAGE FORM THROUGH EXTRUSION WITHOUT PROOF OF ABUSE THAT CONTAINS IN ADDITION, OF ONE OR MORE PRINCIPLES OF SUSCEPTIBLE ABUSE AND OPTIONALLY PHYSIOLOGICALLY UNDERLY NATURALLY ACCEPTED SUBSTANCES AT LEAST 500 NY A PREPARATION PROCESS OF THE SAME.

CL2004002016A 2003-08-06 2004-08-06 THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST CL2004002016A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10336400A DE10336400A1 (en) 2003-08-06 2003-08-06 Anti-abuse dosage form
DE10361596A DE10361596A1 (en) 2003-12-24 2003-12-24 Process for producing an anti-abuse dosage form
DE102004020220A DE102004020220A1 (en) 2004-04-22 2004-04-22 Process for the preparation of a secured against misuse, solid dosage form

Publications (1)

Publication Number Publication Date
CL2004002016A1 true CL2004002016A1 (en) 2005-05-20

Family

ID=40261417

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2004002016A CL2004002016A1 (en) 2003-08-06 2004-08-06 THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST

Country Status (1)

Country Link
CL (1) CL2004002016A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9629807B2 (en) 2003-08-06 2017-04-25 Grünenthal GmbH Abuse-proofed dosage form
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US9750701B2 (en) 2008-01-25 2017-09-05 Grünenthal GmbH Pharmaceutical dosage form
US10058548B2 (en) 2003-08-06 2018-08-28 Grünenthal GmbH Abuse-proofed dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
US10130591B2 (en) 2003-08-06 2018-11-20 Grünenthal GmbH Abuse-proofed dosage form
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
US10201502B2 (en) 2011-07-29 2019-02-12 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US10300141B2 (en) 2010-09-02 2019-05-28 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
US10369109B2 (en) 2002-06-17 2019-08-06 Grünenthal GmbH Abuse-proofed dosage form

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10369109B2 (en) 2002-06-17 2019-08-06 Grünenthal GmbH Abuse-proofed dosage form
US9629807B2 (en) 2003-08-06 2017-04-25 Grünenthal GmbH Abuse-proofed dosage form
US10130591B2 (en) 2003-08-06 2018-11-20 Grünenthal GmbH Abuse-proofed dosage form
US10058548B2 (en) 2003-08-06 2018-08-28 Grünenthal GmbH Abuse-proofed dosage form
US9750701B2 (en) 2008-01-25 2017-09-05 Grünenthal GmbH Pharmaceutical dosage form
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
US10300141B2 (en) 2010-09-02 2019-05-28 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
US10201502B2 (en) 2011-07-29 2019-02-12 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US10864164B2 (en) 2011-07-29 2020-12-15 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles

Similar Documents

Publication Publication Date Title
CL2004002017A1 (en) THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE ABUSE PRINCIPLES, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A SYNTHETIC OR NATURAL POLYMER OF A DEFINED GROUP AND (D) OPTIONAL
AR045353A1 (en) ABUSE PROOF DOSAGE FORM
AR046994A1 (en) PROCESS FOR THE PRODUCTION OF AN ABUSE PROOF DOSAGE FORM
CL2004002016A1 (en) THERMOFORMED DOSAGE FORM FOR PROOF OF ABUSE CONTAINING (A) ONE OR MORE SUSCEPTIBLE ACTIVE PRINCIPLES OF ABUSE, (B) OPTIONALLY AUXILIARY SUBSTANCES, (C) AT LEAST A DEFINED SYNTHETIC OR NATURAL POLYMER AND (D) OPTIONALLY AT LEAST
BR0015188A (en) Pharmaceutical compositions
UY27586A1 (en) CIS- IMIDAXOLINAS
BG66093B1 (en) Controlled release compositions comprising nimesulide
UY28509A1 (en) DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS
ECSP066759A (en) COMBINATIONS OF INSECTED ACTIVE PRODUCTS BASED ON THIACLOPRID AND PIRETROIDES
ATE304368T1 (en) MEDICINAL PRODUCTS CONTAINING HERBAL PLANTS
DE60327103D1 (en) PHARMACEUTICAL FORMS CONTAIN A PROTON PUMP, A NAZID AND A BUFFER
DE60131760D1 (en) DEVICE FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE ACTIVE IN POWDER FORM
ES2195638T3 (en) PREPARATIONS OF PHARMACEUTICAL COMBINATIONS IN SOLID FORM OF DOSAGE CONTAINING CARDEVILOL AND HYDROCLOROTIAZIDA.
ATE354362T1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHIC ACTIVE INGREDIENT
UY27929A1 (en) PHARMACEUTICAL COMPOSITIONS OF SEMIORDENED AND POLYMER DRUGS
DE60102590D1 (en) PHARMACEUTICAL FORMS FOR TREATING ORAL MYCOSIS
AR039232A1 (en) A PHARMACEUTICAL FORMULATION THAT INCLUDES AT LEAST A SELECTED COMPOSITE OF THE GROUP FORMED BY NON-BARBITURIC HYPNOTICS AND NON-BENZODIACEPINICS, AND MELATONIN
BR0115775B1 (en) a package comprising a container and a membrane.
AU2001258299A1 (en) An efficacious dosage regimen of galantamine that reduces side effects
ATE297760T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TERBINAFIN
ATE338567T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING ACTIVE INGREDIENTS SUITABLE FOR UNAUTHORIZED ADMINISTRATION
DE602005010203D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 2,4-DICHLOROBENZYL ALCOHOL AND AMYLMETAKRESOL
GT200400183A (en) DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS
DE60312642D1 (en) PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE
ATE269061T1 (en) CALCIUM-CONTAINING effervescent TABLET WITH AN ANTHISTAMINIC AS THE ACTIVE INGREDIENT